Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial - BMC Medicine

Submitted by Anonymous (not verified) on Wed, 03/05/2025 - 02:48

Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial BMC Medicine

Log in to post comments